Global Oral Proteins and Peptides Market to Benefit from High Incidence of Tumors and Diabetes

Transparency Market Research offers a complete analysis of the global oral proteins and peptides market in a new research report. The research report, titled “Oral Proteins and Peptides Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” assesses the market using Porter’s five forces analysis to determine the intensity of competitive rivalry, the threat of new entrants, the bargaining power of suppliers, the threat of substitute products or services, and the bargaining power of customers. 

Additionally, the report also includes SWOT analysis to shed light on the strengths, weaknesses, opportunities, and threats shaping the segments of the global oral proteins and peptides market. For a holistic point of view, the researchers have scrutinized the micro and macro operational functionalities along with the trends and dynamics shaping the overall market.

Earlier, pharmaceutical formulations that had proteins and peptides were given to patients through intravenous or subcutaneous ways due to their sensitivity and instability towards body fluids. With increasing research and development activities and growing technological advancements, researchers have created protein formulations that are prescribed for oral intake without disturbing the pharmacokinetic aspects and the therapy. Owing to these reasons, the global oral proteins and peptides market is expected to grow at a steady rate. Furthermore, the high incidence of tumors, diabetes, and other disorders will also propel this market. 

The global oral proteins and peptides market is segmented on the basis of drug, technology, and geography. The drugs available in this market are IN-105 (inslulin), Plecantide Linaclotide, Octreolin, Ostora, and others. The technologies used for developing these formulations are gastrointestinal permeation enhancement technology (GIPET), multi-matrix systems (MMX), peptelligence, eligen, and oral antibody platforms, among others. Geographically, this market is segmented into Europe, North America, Asia Pacific, and Rest of the World.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1962

Currently, North America is leading the global oral proteins and peptides market. However, analysts predict that Asia Pacific and other countries from the Rest of the World will show a good growth rate in the coming few years.

Some of the important players in the global oral proteins and peptides market are Abbott Laboratories, ZydusCadilla Healthcare, Sanofi-Aventis LLC, Pfizer, Inc., Johnson & Johnson, Novartis AG, and Roche, Inc., amongst others. The research report profiles these players and offers a fair analysis of the competitive landscape of the global oral proteins and peptides market. Furthermore, the report also provides an insightful take on the regulatory framework governing these players as well as the research and development activities, financial overview, investment outlook, product portfolio, and business and marketing activities of these players.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.